News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Pronota Strengthens Board with Appointment of Chairman
June 4, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Ghent, Belgium; 29 May 2007 - Pronota nv, the Belgium-based predictive biomarker company, has announced the appointment of Mr John Berriman as Chairman, with immediate effect.
Twitter
LinkedIn
Facebook
Email
Print
People
Europe
MORE ON THIS TOPIC
Cancer
Sellas’ cancer vaccine slashes death risk by 41% in late-stage AML study
November 17, 2026
·
2 min read
·
Gabrielle Masson
Licensing
Lilly pens another deal, inking up to $5.9B oncology pact with Stipple
November 17, 2026
·
1 min read
·
Annalee Armstrong
Earnings
Genetix’s genetic medicines are officially profitable, with $327M in sales YTD
November 17, 2026
·
3 min read
·
Annalee Armstrong
Funding
Marrow Therapeutics debuts with $173M to tackle blood disorders in vivo
November 17, 2026
·
2 min read
·
Gabrielle Masson